Hasil Pencarian - Walter Jeske PhD

  • Menampilkan 1 - 14 hasil dari 14
Perbaiki Hasil
  1. 1
    Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

    Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum oleh Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Walter Jeske PhD, Omer Iqbal MD, Alfonso Tafur MD, Jawed Fareed PhD

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa

    Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa oleh Joseph Lewis BA, Omer Iqbal MD, Walter Jeske PhD, Debra Hoppensteadt PhD, Fakiha Siddiqui BDS, Jawed Fareed PhD

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components

    Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components oleh Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Emily Bontekoe BS, Ambar Farooqui MD, Walter Jeske PhD, Jawed Fareed PhD

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate

    Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate oleh Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Walter Jeske PhD, Eduardo Ramacciotti MD, PhD, Alfonso Tafur MD, MS, MBA, Jawed Fareed PhD, FAHA

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates

    Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates oleh Ahmed Kouta MS, MBA, Walter Jeske PhD, Lee Cera DVM, PhD, Azarfrooz Farshid DVM, Richard Duff BS, CVT (AVMA), Debra Hoppensteadt PhD, Jawed Fareed PhD

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates

    Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates oleh Ahmed Kouta MS, MBA, Debra Hoppensteadt PhD, Emily Bontekoe BSc, Walter Jeske PhD, Richard Duff BS, CVT (AVMA), Lee Cera DVM, PhD, Jawed Fareed PhD

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa

    Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa oleh Fakiha Siddiqui BDS, Alfonso Tafur MD, Emily Bontekoe BS, Omer Iqbal MD, Walter Jeske PhD, Siddharth Mehrotra, Debra Hoppensteadt PhD, Eduardo Ramacciotti MD, PhD, Jawed Fareed PhD

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin

    Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin oleh Guy Olson BS, Walter Jeske PhD, Omer Iqbal MD, Emily Krupa BS, Amber Farooqui MD, Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Ahmed Kouta PhD, Jawed Fareed PhD

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values

    Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values oleh Fakiha Siddiqui BDS, Alfonso Tafur MD, Lorenzo Storino Ramacciotti BS, Walter Jeske PhD, Debra Hoppensteadt PhD, Eduardo Ramacciotti MD, PhD, Omer Iqbal MD, FACC, FESC, Jawed Fareed PhD

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis

    Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis oleh Siddharth Mehrotra, Debra Hoppensteadt PhD, Walter Jeske PhD, Fakiha Siddiqui BS, Omer Iqbal MD, Alfonso Tafur MD, Bruce Lewis MD, Mark Jaradeh BS, Bulent Kantarcioglu MD, Jawed Fareed PhD

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism

    Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism oleh Bulent Kantarcioglu MD, Amir Darki MD, MSc, Fakiha Siddiqui BDS, Emily Krupa BS, Mehmet Vural MD, Murat Kacmaz MD, Debra Hoppensteadt PhD, Omer Iqbal MD, Walter Jeske PhD, Jeanine Walenga PhD, Cafer Adiguzel MD, Jawed Fareed PhD

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

    An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations oleh Bulent Kantarcioglu MD, Omer Iqbal MD, Joseph Lewis BA, Charles A. Carter BS, PharmD, MBA, Meharvan Singh PhD, Fabio Lievano MD, Mark Ligocki DDS, Walter Jeske PhD, Cafer Adiguzel MD, Grigoris T. Gerotziafas MD, Jawed Fareed PhD

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination

    An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination oleh Bulent Kantarcioglu MD, Omer Iqbal MD, Jeanine M. Walenga PhD, Bruce Lewis MD, Joseph Lewis BS, Charles A. Carter BS, PharmD, MBA, Meharvan Singh PhD, Fabio Lievano MD, Alfonso Tafur MD, Eduardo Ramacciotti MD, PhD, Grigoris T. Gerotziafas MD, Walter Jeske PhD, Jawed Fareed PhD

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin

    Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin oleh Jianle Chen BS, Yanlei Yu PhD, Jawed Fareed PhD, Debra Hoppensteadt PhD, Walter Jeske PhD, Ahmed Kouta BS, Caijuan Jin MS, Yongsheng Jin MS, Yiming Yao MS, Ke Xia PhD, Fuming Zhang PhD, Shiguo Chen PhD, Xingqian Ye PhD, Robert J. Linhardt PhD

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: